First Trust Direct Indexing L.P. Sells 49 Shares of Humana Inc. (NYSE:HUM)

First Trust Direct Indexing L.P. cut its holdings in Humana Inc. (NYSE:HUM) by 1.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,235 shares of the insurance provider’s stock after selling 49 shares during the quarter. First Trust Direct Indexing L.P.’s holdings in Humana were worth $1,122,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in HUM. Rakuten Securities Inc. purchased a new stake in shares of Humana during the fourth quarter valued at $25,000. Gradient Investments LLC grew its stake in shares of Humana by 200.0% in the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 40 shares during the period. Cetera Trust Company N.A bought a new stake in shares of Humana in the fourth quarter worth approximately $28,000. Private Wealth Management Group LLC purchased a new position in shares of Humana during the fourth quarter valued at approximately $32,000. Finally, Carolinas Wealth Consulting LLC lifted its position in Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after purchasing an additional 74 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Trading Down 3.2 %

Shares of NYSE HUM opened at $362.85 on Friday. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $530.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The business’s 50 day moving average is $347.65 and its two-hundred day moving average is $349.45. The stock has a market capitalization of $43.72 billion, a P/E ratio of 22.59, a PEG ratio of 2.10 and a beta of 0.51.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The company’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $9.38 EPS. As a group, research analysts expect that Humana Inc. will post 16.27 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.98%. Humana’s dividend payout ratio is presently 22.04%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Morgan Stanley initiated coverage on Humana in a report on Monday, June 24th. They set an “equal weight” rating and a $374.00 price target on the stock. Oppenheimer dropped their price objective on shares of Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a report on Thursday, April 25th. Royal Bank of Canada reduced their price objective on Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research note on Thursday, April 25th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $360.00 target price on shares of Humana in a report on Wednesday, June 12th. Finally, Piper Sandler started coverage on Humana in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price target for the company. Fourteen equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $409.55.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.